With its headquarters located in Hyderabad, India, Aurobindo Pharma Limited (ARBP) is a comprehensive worldwide pharmaceutical enterprise. The corporation operates in over 150 countries and is involved in the research, production, and marketing of a broad variety of specialty pharmaceuticals, generic ...
With a market valuation of Rs 59,033.31 Cr, Aurobindo Pharma Ltd is a blue-chip company in the healthcare industry. Apart from dominating the Semi-Synthetic Penicillin market, it is also present in key therapeutic areas including anti-biotics, gastroenterology, anti-retrovirals, neurosciences, and cardiology. ...
Generic pharmaceuticals company, Aurobindo Pharma's share price touched a new 52-week high on Monday after recording highest highest-ever sales in Q2FY4 and declaring an interim dividend for the fiscal. Brokerage Prabhudas Lilladher believes that Aurobindo's US business will further scale up. ...
Leading brokerage firm Geojit has picked 2 pharma sector stocks with a "Buy" tag. These 2 stocks are Strides Pharma Science Ltd. and Aurobindo Pharma Ltd. The brokerage rated the "Buy" with an attractive target price. It sees robust gains of ...
Sharekhan by BNP Paribas has assigned hold rating to 2 large cap stocks operating in Pharmaceuticals Sector. These 2 stocks are Cipla Ltd and Aurobindo Pharma Ltd. If you hold shares of these 2 large caps, you can potentially get 14% return. Check details below: ...
Aurobindo Pharma Ltd, a midcap leading Pharma sector stock, has recently declared 300% Interim dividend in its Board Meeting held on 9 February 2023. The stock has recently hit the 52 week low, however, it jumped nearly 20% from its lows. ...
BNP Parisbas Securities has recommended investors to buy three pharmaceuticals stocks showing rising trend. These stocks are JB Chemicals & Pharmaceuticals Ltd, Dr. Lal Pathlabs Ltd, and Aurobindo Pharma Ltd. 2 of these pharma stocks are currently trading near their 52-week ...
Today four leading companies' stocks hit their new 52-week low in trade. These stocks are Divi's Laboratories Ltd, Aurobindo Pharma Ltd, Bandhan Bank Ltd, and MphasiS Ltd. There is an opportunity to buy these stocks at lower prices. Divi's Laboratories ...
The brokerage firm Geojit, in its retail equity research report on Aurobindo Pharma Limited, a mid-cap pharmaceuticals company, has suggested 'buy' the stock for a target price of Rs 645 apiece. If we consider the brokerage's estimated target price, the stock ...
Leading brokerage firm KR Choksey has given buy rating to the pharmaceuticals sector stock Aurobindo Pharma Ltd for a target price of Rs 626 apiece with a potential gain of 10%. Aurobindo reported revenue growth of 9.4% YoY (+7.3% QoQ) to ...
Today, June 27, Aurobindo Pharma, a pharmaceuticals company, informed the stock exchanges that it had received a "warning letter" from the Securities and Exchange Board of India (SEBI) regarding the US Food and Drug Administration (USFDA) audit at its Hyderabad facility. ...